iiinova — where your digital self keeps evolving

International Society of Glomerular Disease @isgd.bsky.social · 24/09/2026

⏰ Time is running out! Registration for the ISGD Clinical Trials Summit 2026 closes October 1. Meet the industry experts. Connect with leaders. Be part of what’s next. 📅 November 13–15, 2026 | Galveston, TX 🔗 Register now: www.is-gd.org/2026-cts #ISGD #ClinicalTrials

000

International Society of Glomerular Disease @isgd.bsky.social · 22/09/2026

Clinical trial bootcamp training @ ALANEPE Congress 2026 🇦🇷. ISGD is proud to host our Clinical Trials Bootcamp on Oct. 28 in Mar del Plata, Argentina. Looking forward to provide this training to over 120 Latam peds nephs! Learn more: www.is-gd.org/ctbalanepe #ISGD #ALANEPE2026

020

International Society of Glomerular Disease @isgd.bsky.social · 11/09/2026

Don't Wait. Submit Now. Late-Breaking Abstracts Open Through October 1.

000

International Society of Glomerular Disease @isgd.bsky.social · 10/09/2026

🚀 The future of pediatric clinical trials starts here! ISGD Pediatric Clinical Trials Bootcamp is coming to ESPN 2026. Practical training, mentorship & networking to prepare the next generation of trial investigators 👉 Register now! congressespn.org/ipna-espn-ju... #ISGD #ESPN2026 #ClinicalTrials

030

International Society of Glomerular Disease @isgd.bsky.social · 08/09/2026

ISGD meets in Philadelphia. A meaningful visit to the Hospital of the University of Pennsylvania brought together colleagues, clinical perspectives, and important conversations about the future of glomerular medicine. Connecting. Learning. Advancing. Together. @tobias-b-huber.bsky.social

000

International Society of Glomerular Disease @isgd.bsky.social · 04/09/2026

Six more experts. Six more perspectives. One big goal. 🔬 Meet more of the incredible speakers joining the ISGD Clinical Trials Summit in Galveston, Nov. 13–15! 🌎 Clinical trials. Collaboration. The future of glomerular medicine. 👉 is-gd.org/2026-CTS

000

International Society of Glomerular Disease @isgd.bsky.social · 03/09/2026

🌊 Your research belongs in Galveston! The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts! 📅 Opens Sept. 1 ⏰ Deadline Oct. 1 Share your latest research with leaders in glomerular disease. 🔬 Submit: www.is-gd.org/cts-2026-lat...

000

International Society of Glomerular Disease @isgd.bsky.social · 25/08/2026

100

International Society of Glomerular Disease @isgd.bsky.social · 21/08/2026

🌎 ISGD welcomes 4 new Board leaders! 🔬 Kretzler — translational research 🧪 Rovin — clinical trials 👧 Vivarelli — pediatric nephrology 💜 Lightstone — lupus nephritis & patient advocacy 👉 Read more: www.is-gd.org/en/news-from...

is-gd.org

ISGD Welcomes 4 New Board Appointments

ISGD Welcomes Four New Board Appointments

020

International Society of Glomerular Disease @isgd.bsky.social · 18/08/2026

ISGD’s Clinical Trials BootCamp is building the next generation of trial-ready kidney investigators and sites through education, mentorship & collaboration. Featured in *ASN Kidney News*. **Why ISGD? Why Now?** Read more: www.kidneynews.org/view/journal... #ISGD #ClinicalTrials

kidneynews.org

010

International Society of Glomerular Disease @isgd.bsky.social · 06/08/2026

✨ Only 100 days until the inaugural 2026 ISGD Clinical Trials Summit! We’re spotlighting our outstanding Program Advisory Committee, whose expertise is shaping an exciting, forward-thinking program. Join us in Galveston! 🌎 🧬 Register Now: www.is-gd.org/2026-cts @tobias-b-huber.bsky.social

021

International Society of Glomerular Disease @isgd.bsky.social · 30/07/2026

🚨 The countdown is on! August 1 is your last chance to save with early registration and submit your abstract for the inaugural ISGD Clinical Trials Summit, hosted by UTMB. Join us Nov. 13–15 in Galveston, TX. 🔗 Register: www.is-gd.org/2026-cts ➤ Submit your abstract: www.is-gd.org/cts-2026-abs...

110

International Society of Glomerular Disease @isgd.bsky.social · 24/07/2026

🚨 August 1 is almost here! Register early and submit your abstract for the 2026 ISGD Clinical Trials Summit, hosted by UTMB. Join leading experts in glomerular disease Nov. 13–15 in Galveston, TX! Register today: www.is-gd.org/2026-cts Submit an Abstract: www.is-gd.org/cts-2026-abs...

110

International Society of Glomerular Disease @isgd.bsky.social · 20/07/2026

🎙️New #GNin10 Ready to level up your MN knowledge from IgG1 to IgG4? 🧬 In our latest Board Review Bonus, Dr. Kenar Jhaveri & Dr. Koyal Jain break down Membranous Nephropathy—from biopsy "spikes" to the "Koyal-Kenar" risk criteria! 🎧 share.transistor.fm/s/03967a4b ⛱️ PARASOL-MN: is-gd.org/parasol

101

International Society of Glomerular Disease @isgd.bsky.social · 05/07/2026

🍁 We wrapped up June with another ISGD Preceptorship at @uoftmedicine.bsky.social! Thanks Arenn Jauhal & Heather Reich for a fascinating 2-day program on complement-mediated GD! Learned so much & worked on solving so many problems 🍁 The GD patients of Canada are in very good hands!

040

International Society of Glomerular Disease @isgd.bsky.social · 02/07/2026

When we say the International Society of Glomerular Disease, we mean INTERNATIONAL. 🌍 In partnership with UTMB, the inaugural ISGD Clinical Trials Summit 2026 brings together speakers from 12+ countries and scholarship applicants from 5+ countries. Register now: www.is-gd.org/2026-cts #ISGD #UTMB

120

International Society of Glomerular Disease @isgd.bsky.social · 24/06/2026

📢 Abstract deadline extended! Submit your work to ISGD's Inaugural Clinical Trials Summit by August 1, 2026. Share innovations in kidney disease clinical trials, biomarkers, patient engagement, trial design and more! 🔗 www.is-gd.org/cts-2026-abs... #ISGD #KidneyResearch @tobias-b-huber.bsky.social

010

International Society of Glomerular Disease @isgd.bsky.social · 23/06/2026

💗 Congrats to @tobias-b-huber.bsky.social, honored with this year's Münster Heart Center Lecture! 🫀 A well-deserved recognition of the vital link between kidney & heart health. He also signed Münster’s historic Golden Book in the Hall of Peace, joining the likes of Obama, the Dalai Lama & QEII 📖

010

International Society of Glomerular Disease @isgd.bsky.social · 19/06/2026

🚨New GN in 10🎙️ Think Alport's only affects males 🧬? Think again! @kdjhaveri.bsky.social & Koyal Jain provide a comprehensive clinical overview of hereditary nephritis—aka Alport syndrome. 🎧 Listen here: share.transistor.fm/s/434d7408 #AlportSyndrome #ISGD #GNin10 @tobias-b-huber.bsky.social

100

International Society of Glomerular Disease @isgd.bsky.social · 13/06/2026

🔬 Join leading experts at ISGD’s first Clinical Trials Summit this November! Explore the latest in GD regulatory advances, patient engagement, biomarkers, and recruitment strategies! 🗓️ Nov 13–15, 2026 📍 Galveston, TX 🔗 www.is-gd.org/2026-cts #ISGD #ClinicalTrials @tobias-b-huber.bsky.social

000

International Society of Glomerular Disease @isgd.bsky.social · 08/06/2026

#ERA26 🏴󠁧󠁢󠁳󠁣󠁴󠁿✨ Challenging our thinking in nephrology and in glomerular diseases. Proud to see many members taking center stage. The ISGD team was grateful to spend time with so many of our members and partners committing to better outcomes and lives for our patients. #GlomerularDisease #KidneyHealth

020

International Society of Glomerular Disease @isgd.bsky.social · 01/06/2026

Starting the week with an ISGD Preceptorship at the UK’s National Renal Complement Therapeutics Centre 🤩 @newcastleuni.bsky.social

000

International Society of Glomerular Disease @isgd.bsky.social · 26/05/2026

🚨 Late-Breaking Abstract Submissions are open for the 2026 ISGD Clinical Trials Summit! Share your findings with the global glomerular disease research community. 🗓️ Nov 13–15, 2026 📍 Galveston, TX Submit: www.is-gd.org/cts-2026-abs...  Register: www.is-gd.org/2026-cts @tobias-b-huber.bsky.social

000

International Society of Glomerular Disease @isgd.bsky.social · 18/05/2026

The updated ISGD Clinical Trials Summit Agenda Highlights are here! FDA panels, patient voices, late-breaking research, trial innovation, and more! @tobias-b-huber.bsky.social 🗓️ Nov 13–15, 2026 📍Galveston, TX Register: www.is-gd.org/2026-cts #ISGD #ClinicalTrials #Nephrology #KidneyResearch

000

International Society of Glomerular Disease @isgd.bsky.social · 01/05/2026

New GN in 10 Board Review Bonus! 🎧 Hosts @kdjhaveri.bsky.social & Dr. Koyal Jain tackle the complexities of Kidney Amyloidosis. From "mushy" microscopy to the precision of mass spectrometry, this episode is a must-listen for the global #NephTwitter community. Listen here: bit.ly/4cIvNkP

132

International Society of Glomerular Disease @isgd.bsky.social · 28/04/2026

The time is finally here: A sneak peek of the Agenda Highlights for ISGD’s 2026 Clinical Trial Summit with UTMB, bringing together leaders advancing glomerular disease research. Join us Nov. 13–15, 2026 in Galveston, TX. Register: www.is-gd.org/2026-cts Questions/sponsorship: ctsummit@is-gd.org

111

Reposted by International Society of Glomerular Disease

NephMadness @nephmadness.bsky.social · 28/04/2026

Thank you to these podcasts on #NephMadness 2026: - GN in Ten @isgd.bsky.social - Global Kidney Care @theisn.org - @freelyfiltered.bsky.social - @febrilepodcast.com - @nkf-professionals.bsky.social - @coreimpodcast.bsky.social - Nephron Segment bit.ly/NM26podcrawl

142

International Society of Glomerular Disease @isgd.bsky.social · 14/04/2026

More than 100 years after #FSGS was first described, we have the first FDA-approved treatment. A proud day for the collaborative #ParasolProject! With the global community uniting to transform glomerular health, this is only the beginning. ⛱️

is-gd.org

A Milestone for FSGS — And a Proud Moment for PARASOL

A historic milestone for FSGS patients as the FDA approves the first drug for the condition, highlighting the collaborative efforts behind the PARASOL project's success.

151

International Society of Glomerular Disease @isgd.bsky.social · 30/03/2026

♨️ Debate at WCN26: Should complement inhibition be considered before targeted-release budesonide in patients with IgAN at risk of progression? A key discussion between upstream vs downstream treatment strategies in IgAN. 🧵(1) #ISNWCN #GlomerularDisease

110

International Society of Glomerular Disease @isgd.bsky.social · 30/03/2026

#ISNWCN “KDIGO IgAN Session” discussing so interesting cases and perspectives 🇺🇸🇨🇳🇯🇵 🔎Effect of therapies on GFR loss and proteinuria 🎯Novel agents 👉🏻Disease activity and clinical background are important to determine appropriate therapy #GlomerularDisease #KidneyHealthMatters 🌎🫘🌸

041

International Society of Glomerular Disease @isgd.bsky.social · 30/03/2026

“Understanding and Treating Complement-Mediated Glomerular Disease” #ISNWCN #ISGD ✅KPMP: right treatment, right person, right time 🧬Haplotype and Disease Penetrance- Genetic testing ❌C5b-9: more severe disease 🖊️C5a in AAV - complement therapies 🎯”RESET into homeostasis” #GlomerularDisease

041

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

🌟 Enjoying our #WCN2026 coverage? A heartfelt thank you to our incredible ISGD social media ambassadors, Dr. @gabyneph.bksy.social and Dr. Belén Gallegos, for bringing us the latest updates and insights in glomerular disease and keeping our community informed and engaged 🙌 #ISGD #GlomerularDisease

000

Reposted by International Society of Glomerular Disease

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 29/03/2026

Applications are open for the next class of the #NephJC internship Apply here www.nephjc.com/news/nephjc-... or scan the QR code #ISNWCN

QR code for https://www.nephjc.com/news/nephjc-editorial-internship

043

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

⛩️ Together in Yokohama at #ISNWCN with presidents of ERA, @theisn.org and @isgd.bsky.social ! ⛩️ @rosertorra.bsky.social, Marcello Tonelli, and @tobias-b-huber.bsky.social + Ron Gansevoort

020

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

At WCN’26, Tobias Huber highlighted the mission of the ISGD: uniting a 🌎 community to connect, educate, and advance research to improve care for patients with #GlomerularDisease With 1,700+ members across 102 countries, #ISGD is building a 🌎 network for innovation and collaboration in 🫘 disease

020

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

Heather Reich ISGD Chair of the Membership & Accreditation Committee, is present at the WCN’26 🤩 A great session about exploring the role of APRIL in IgAN 👉🏻 A great discussion of clinical scenarios #ISGD #GlomerularDisease #ISNWCN

000

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

Amazing! Paola Romagnani #ISGD #ISNWCN with “Podocytopathies: Knowns and Unknowns” 👉🏻Podocyte loss and regeneration 👀Autoimmune, genetic, adaptive, infectious, toxic, monoclonal 🎯Anti-slit autoantibodies-> ⬇️ prognosis #GlomerularDisease #Yokohama 🌸

132

International Society of Glomerular Disease @isgd.bsky.social · 29/03/2026

Our ISGD president Tobias Huber is present at the WCN’26 🌸 👉🏻 His first session of the day: Kidney tissue-specific gene targeting 🦠 Adenovirus as a potential vector for gene targeting therapies #ISNWCN #GlomerularDisease #ISGD

000

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

🤔 Where is pathogenic IgA produced❓ 👉🏻 B cells induced in MALT can migrate to the bone marrow and differentiate into IgA-PC there 💉💊 We have emerging therapies to target B cells in Ivan but we still need a better understanding of the pathophysiology #ISNWCN @theisn.org

031

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

021

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

🤔 What makes IgA pathogenic in IgAN❓ 👉🏻 A subgroup of GdIgA1with strong affinity for the glomerulus 🫘 💡 IgA type anti-MEsangial Cell Antibodies (Ig-MESCA) are GdIgA1-Ab. 🎯 Mesangial cells 🧫 Molecular mimicry with oral bacteria #ISNWCN @theisn.org

043

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

INShore Phase 3 trial: Obinutuzumab vs MMF in childhood-onset FRNS/SDNS to maintain remission 85 patients / 9 countries Type II anti-CD20 therapy → ⬇️ B-cell depletion Primary endpoint met: sustained remission at 52 wks significantly ⬆️ w/obinutuzumab #ISNWCN @ISNKidneycare

070

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

So interesting! “Cutting Edge Science in Nephrotic Syndrome/FSGS” #Yokohama #ISNWCN *Autoimmune Diseases treatments *B cell depletion - How broad? *Prognosis given by antibodies *Anti-human and anti-mouse CD39 antibodies Amazing treatment options #GLOMERULARDISEASE

031

International Society of Glomerular Disease @isgd.bsky.social · 28/03/2026

"Finally in #Yokohama for 'Renal Pathology: Native Kidney Disease Pathology.' Covering IgG4-related disease, parasitic glomerular lesions, and genomics in Undeterminate Kidney Disease. Follow for more updates. #Nephrology #GlomerularDisease #Genomics

001

International Society of Glomerular Disease @isgd.bsky.social · 26/03/2026

🤔 Do not know which session to attend in the WCN’26? @Tobias_B_Huber is giving this amazing session: 📌 Autoantibodies targeting podocyte-specific antigens in primary nephrotic syndrome 🗓️ Sunday, 29 March ⏰ 15:50 📍 304

000

International Society of Glomerular Disease @isgd.bsky.social · 26/03/2026

👀 Attending the WCN’26? 👉🏻 Do not miss this interesting talk: 🐺 CAR-T cell therapy in lupus 🗓️ Monday, 30 Mar 2026 ⏰ 09:50 📍 301-302 Speaker: @BradRovin #ISNWCN @ISNKidneycare

021

International Society of Glomerular Disease @isgd.bsky.social · 24/03/2026

Attention Fellows & Early Career Nephrologists! 🚀 🤓 10 scholarships (up to $1,500) are available for the RPA/ISGD Clinical Trial Bootcamp in Atlanta on April 16. Build your roadmap for research in private practice. ⏳ Apply (First-come, first-served): fk6zr.share-eu1.hsforms.com/2qgYbuOugRBm...

111

International Society of Glomerular Disease @isgd.bsky.social · 20/03/2026

💡Join us for the RPA/ISGD Clinical Trials Bootcamp - designed for community nephrologists to establish robust research programs. Register here: bit.ly/RPA-ISGD-CTB Including: ✔️ Building the Business Plan & ROI ✔️ Executing the Plan ✔️ Support & Logistics ✔️ Strategies for varied practice settings

201

International Society of Glomerular Disease @isgd.bsky.social · 13/03/2026

#ISGD Clinical Trial Bootcamp at the PNRC Fellows Workshop! 🚀 Equipping future investigators with practical steps to turn clinical trials into real-world care. Thanks to Vertex Pharmaceuticals for supporting this important mission! 👏 #Nephrology #ClinicalTrials #ISGD

200

International Society of Glomerular Disease @isgd.bsky.social · 12/03/2026

#WorldKidneyDay is about more than raising awareness—it’s about raising expectations. New video with insights from @tobias-b-huber.bsky.social and Barbara Gillespie, MD, FASN and a preview of coming attractions at our Clinical Trials Summit! @hcplivenews.bsky.social www.hcplive.com/view/clinica...

Top 5 game changers in 2026 according to Tobias B. Huber and Barbara Gillespie:
1. Surrogate endpoint advances in FSGS and MN
2. New IgAN trial designs and combining therapies
3. Molecular stratification of diseases - moving from histotypes to endotypes
4. Hierarchical compasite endpoints
5. Cell and gene therapies and collaboration across specialties

020